REQUEST A DEMO
Total
USD $0.00
Search more companies

Kbc Company Public Joint Stock (Kbc Public Shareholding Company) (Iran)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Kbc Company Public Joint Stock Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

KBC Co. is an Iranian company established in 1954. The company’s main business is the importation of speciality pharmaceuticals and medical products. For more than half a century KBC Co. has been supplying the Iranian market with healthy and high-quality products. For several years KBC has been a close partner of Iran’s MOH, supplying the government with its needed and requested products. KBC has a unique experience in the importation of vaccines and blood derivatives. KBC has close relations with big companies such as Merck Serono, Ferring Pharmaceutical, and Serum.

Headquarters
Argentina Square, Alvand St, Aviz Alley, No. 5, 5Th Floor
Tehran; Tehran; Postal Code: 1516914615

Contact Details: Purchase the Kbc Company Public Joint Stock (Kbc Public Shareholding Company) report to view the information.

Website: http://www.kbcco.com

Basic Information
Total Employees:
Purchase the Kbc Company Public Joint Stock (Kbc Public Shareholding Company) report to view the information.
Outstanding Shares:
Purchase the Kbc Company Public Joint Stock (Kbc Public Shareholding Company) report to view the information.
Financial Auditors:
Purchase the Kbc Company Public Joint Stock (Kbc Public Shareholding Company) report to view the information.
Incorporation Date:
January 15, 2026
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
48%
Purchase this report to view the information.
31.39%
Purchase this report to view the information.
0.21%
Purchase this report to view the information.
0.21%
Purchase this report to view the information.
0.21%
Company Performance
Financial values in the chart are available after Kbc Company Public Joint Stock (Kbc Public Shareholding Company) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
58.24%
Total operating revenue
55.85%
Operating profit (EBIT)
357%
EBITDA
N/A
Net Profit (Loss) for the Period
16.7%
Total Assets
45.97%
Total Equity
925.14%
Operating Profit Margin (ROS)
10.95%
Net Profit Margin
12.89%
Return on Equity (ROE)
662.07%
Debt/Equity
-2879.15%
Quick Ratio
-0.12%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?